TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $18,515,000 | +10.3% | 390,294 | -14.8% | 1.14% | +28.1% |
| Q1 2015 | $16,788,000 | -17.9% | 458,202 | -11.1% | 0.89% | -15.6% |
| Q4 2014 | $20,456,000 | +106.0% | 515,159 | +3.5% | 1.06% | +109.1% |
| Q3 2014 | $9,932,000 | +531.8% | 497,858 | +327.1% | 0.51% | +593.2% |
| Q2 2014 | $1,572,000 | -52.6% | 116,556 | -61.7% | 0.07% | -49.7% |
| Q1 2014 | $3,317,000 | – | 304,682 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |